Report on the results of a clinical trial of a drug for the treatment of COVID-19
15 October 2020
In the shortest possible time, CPD prepared and submitted a report on the results of a phase III clinical trial of an innovative Russian drug for the treatment of patients with COVID-19. This clinical study involved 220 patients with COVID-19 in 12 centers in the territory of the Russian Federation.